GERALD MCMAHON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Celldex Therapeutics, Inc.

Filing Date Source Excerpt
2017-04-28 Gerald McMahon became a director of Celldex in December 2016. The following table summarizes the annual compensation for our non-employee directors during 2016. Gerald McMahon Fees Earned or Paid in Cash $9,625 Option Awards $20,062 Total $29,687
2018-04-30 Gerald McMahon Age 63 Year First Became Director 2016 The following table summarizes the annual compensation for our non-employee directors during 2017. Gerald McMahon Fees Earned or Paid in Cash $45,000 Stock Awards $23,200 Option Awards $23,345 Total $91,545

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2012-11-19 Gerald McMahon(4) 95,800 * Includes options to purchase 95,800 shares of common stock, which are exercisable on November 1, 2012 or within 60 days thereafter.
2016-10-03 Gerald McMahon Includes 85,981 shares Dr. McMahon has the right to acquire currently or within 60 days of September 15, 2016, upon the exercise of options.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22